Loading...

Teligent, Inc.

TLGTNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.17
$-0.03(-13.85%)

Teligent, Inc. (TLGT) Company Profile & Overview

Explore Teligent, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Teligent, Inc. (TLGT) Company Profile & Overview

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Timothy Sawyer

Contact Information

16096971441
105 Lincoln Avenue, Buena, NJ, 08310

Company Facts

142 Employees
IPO DateJul 30, 1981
CountryUS

Frequently Asked Questions